1. Acknowledgement to Referees

   Acknowledgement to Referees Open access 09 November 2021 Pages: 359 - 360

2. Improvement of Intranasal Drug Delivery with Intravail^® Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System

   • Adrian L. Rabinowicz
   • Enrique Carrazana
   • Edward T. Maggio

   Review Article Open access 25 August 2021 Pages: 361 - 369

   

3. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2

   • Rosanne Sprute
   • Sofie Schumacher
   • Oliver A. Cornely

   Case Report Open access 05 August 2021 Pages: 371 - 374

   

4. Apixaban Pharmacokinetics and Pharmacodynamics in Subjects with Mild or Moderate Hepatic Impairment

   • Charles E. Frost
   • Van Ly
   • Samira M. Garonzik

   Original Research Article Open access 07 August 2021 Pages: 375 - 384

   

5. The Safety of Agalsidase Alfa Enzyme Replacement Therapy in Canadian Patients with Fabry Disease Following Implementation of a Bioreactor Process

   • Aneal Khan
   • Sandra M. Sirrs
   • the Canadian Fabry Disease Initiative

   Original Research Article Open access 20 September 2021 Pages: 385 - 397

   

6. Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy

   • Pauline Vaflard
   • Xavier Paoletti
   • Christophe Le Tourneau

   Original Research Article Open access 25 September 2021 Pages: 399 - 406

   

7. Prediction of Belimumab Pharmacokinetics in Chinese Pediatric Patients with Systemic Lupus Erythematosus

   • Xuan Zhou
   • Tsung-I Lee
   • Peiming Ma

   Original Research Article Open access 09 October 2021 Pages: 407 - 417

   

8. Effects of Letermovir and/or Methylprednisolone Coadministration on Voriconazole Pharmacokinetics in Hematopoietic Stem Cell Transplantation: A Population Pharmacokinetic Study

   • Kimitaka Suetsugu
   • Shota Muraki
   • Ichiro Ieiri

   Original Research Article Open access 15 October 2021 Pages: 419 - 429

   

9. Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration

   • John Dodd
   • Robert Jordan
   • Carl Spana

   Original Research Article Open access 25 October 2021 Pages: 431 - 443

   

10. The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study

    • Rushuang Chen
    • Zhenming Kang
    • Shunyuan Li

    Original Research Article Open access 09 November 2021 Pages: 445 - 453

    

11. Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection

    • Sneha V. Gupta
    • Marie C. Fanget
    • Erik Mogalian

    Original Research Article Open access 06 November 2021 Pages: 455 - 465

    

12. Comment on: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”

    • Karl-Uwe Petersen

    Letter to the Editor Open access 20 October 2021 Pages: 467 - 468

13. Author’s Reply to Petersen: “Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS”

    • Igor V. Maev
    • Yury A. Kucheryavyy
    • J. Enrique Dominguez‑Munoz

    Letter to the Editor Open access 23 October 2021 Pages: 469 - 470